Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Massachusetts Institute of Technology 1982
• Expertise
• 

  Global Scholarship

  • Research

    • South Korea (Country) 
• Research
• 

  Selected Grants

  • Global Pediatric Clinical Trials Network awarded by Food and Drug Administration 2017 - 2022
  • Human EGFRvIII-specific BiTE for the treatment of Glioblastoma awarded by National Institutes of Health 2015 - 2020
  • Systemic EGFRvIII-targeted bispecific antibody as immunotherapy for glioblastoma awarded by National Institutes of Health 2015 - 2019
  • Biodosimetry High-Throughput Test awarded by DxTerity Diagnostics 2017 - 2018
  • Efficacy of dendritic cell vaccines targeting CMV antigens in glioblastoma awarded by University of Florida 2017 - 2018
  • Duke CTSA (UL1) awarded by National Institutes of Health 2013 - 2018
  • Immunology Quality Assesment Program Option 2 awarded by National Institutes of Health 2014 - 2017
  • Regulatory Guidance for Academic Research of Drugs and Devices awarded by University of North Carolina - Chapel Hill 2017
  • Point of Care Biodosimeter awarded by Department of Health and Human Services 2009 - 2016
  • Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development awarded by National Institutes of Health 2014 - 2015
  • PTN Task Order #4: Hydroxyurea PK awarded by National Institutes of Health 2011 - 2014
  • Clinical Trial Planning in Pompe Disease awarded by National Institutes of Health 2013 - 2014
  • Novel Ondansetron Formulation for Combination Treatment of Psychostimulant Abuse awarded by National Institutes of Health 2009 - 2013
  • CTSA UL awarded by National Institutes of Health 2006 - 2012
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Berglund, JP, Szczepanski, N, Penumarti, A, Beavers, A, Kesselring, J, Orgel, K, Burnett, B, Burks, AW, and Kulis, M. "Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials." The journal of allergy and clinical immunology. In practice 5, no. 4 (July 2017): 1098-1104.  Full Text
    • O'Reilly, EK, Hassell, NJ, Snyder, DC, Natoli, S, Liu, I, Rimmler, J, Amspacher, V, Burnett, BK, Parrish, AB, Berglund, JP, and Stacy, M. "ClinicalTrials.gov reporting: strategies for success at an academic health center." Clinical and translational science 8, no. 1 (February 2015): 48-51.  Full Text
    • Ruiz, J, Gilleskie, GL, Brown, P, Burnett, B, and Carbonell, RG. "Comprehensive hands-on training for influenza vaccine manufacturing: A WHO-BARDA-BTEC partnership for global workforce development." Biochemistry and Molecular Biology Education 42, no. 5 (September 10, 2014): 414-419.  Full Text
    • Ruiz, J, Gilleskie, GL, Brown, P, Burnett, B, and Carbonell, RG. "Comprehensive hands-on training for influenza vaccine manufacturing: a WHO-BARDA-BTEC partnership for global workforce development." Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology 42, no. 5 (September 2014): 414-419.  Full Text
    • O'Reilly, EK, Blair Holbein, ME, Berglund, JP, Parrish, AB, Roth, M-T, and Burnett, BK. "Warning letters to sponsor-investigators at academic health centres - the regulatory "canaries in a coal mine"." Clinical and investigative medicine. Medecine clinique et experimentale 36, no. 6 (December 2013): E290-E296.
    • Morse, MA, Chaudhry, A, Gabitzsch, ES, Hobeika, AC, Osada, T, Clay, TM, Amalfitano, A, Burnett, BK, Devi, GR, Hsu, DS, Xu, Y, Balcaitis, S, Dua, R, Nguyen, S, Balint, JP, Jones, FR, and Lyerly, HK. "Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients." Cancer Immunol Immunother 62, no. 8 (August 2013): 1293-1301.  Full Text  Link to Item
    • Matthay, MA, Anversa, P, Bhattacharya, J, Burnett, BK, Chapman, HA, Hare, JM, Hei, DJ, Hoffman, AM, Kourembanas, S, McKenna, DH, Ortiz, LA, Ott, HC, Tente, W, Thebaud, B, Trapnell, BC, Weiss, DJ, Yuan, JX-J, and Blaisdell, CJ. "Cell therapy for lung diseases report from an NIH-NHLBI workshop, november 13-14, 2012." American Journal of Respiratory and Critical Care Medicine 188, no. 3 (2013): 370-375.  Full Text
    • Morse, MA, Chaudhry, A, Gabitzsch, ES, Hobeika, AC, Osada, T, Clay, TM, Amalfitano, A, Burnett, BK, Devi, GR, Hsu, DS, Xu, Y, Balcaitis, S, Dua, R, Nguyen, S, Jr, JPB, Jones, FR, and Lyerly, HK. "Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients." Cancer Immunology, Immunotherapy 62, no. 8 (2013): 1293-1301.  Full Text
    • Osada, T, Berglund, P, Morse, MA, Hubby, B, Lewis, W, Niedzwiecki, D, Yang, XY, Hobeika, A, Burnett, B, Devi, GR, Clay, TM, Smith, J, and Kim Lyerly, H. "Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects." Cancer Immunol Immunother 61, no. 11 (November 2012): 1941-1951.  Full Text  Link to Item
    • Adamo, JE, Bauer, G, Berro, M, Burnett, BK, Hartman, KA, Masiello, LM, Moorman-White, D, Rubinstein, EP, and Schuff, KG. "A roadmap for academic health centers to establish good laboratory practice-compliant infrastructure." Academic Medicine 87, no. 3 (2012): 279-284.  Full Text
    • Kraus, VB, Burnett, B, Coindreau, J, Cottrell, S, Eyre, D, Gendreau, M, Gardiner, J, Garnero, P, Hardin, J, Henrotin, Y, Heinegård, D, Ko, A, Lohmander, LS, Matthews, G, Menetski, J, Moskowitz, R, Persiani, S, Poole, AR, Rousseau, J-C, Todman, M, and OARSI FDA Osteoarthritis Biomarkers Working Group, . "Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis." Osteoarthritis Cartilage 19, no. 5 (May 2011): 515-542.  Full Text  Link to Item
    • Berro, M, Burnett, BK, Fromell, GJ, Hartman, KA, Rubinstein, EP, Schuff, KG, and Speicher, LA. "Support for investigator-initiated clinical research involving investigational drugs or devices: The clinical and translational science award experience." Academic Medicine 86, no. 2 (2011): 217-223.  Full Text
    • Morse, MA, Hobeika, AC, Osada, T, Berglund, P, Hubby, B, Negri, S, Niedzwiecki, D, Devi, GR, Burnett, BK, Clay, TM, Smith, J, and Lyerly, HK. "An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer." J Clin Invest 120, no. 9 (September 2010): 3234-3241.  Full Text  Open Access Copy  Link to Item
    • Hubby, B, Talarico, T, Maughan, M, Reap, EA, Berglund, P, Kamrud, KI, Copp, L, Lewis, W, Cecil, C, Norberg, P, Wagner, J, Watson, A, Negri, S, Burnett, BK, Graham, A, Smith, JF, and Chulay, JD. "Development and preclinical evaluation of an alphavirus replicon vaccine for influenza." Vaccine 25, no. 48 (2007): 8180-8189.  Full Text
    • Reap, EA, Morris, J, Dryga, SA, Maughan, M, Talarico, T, Esch, RE, Negri, S, Burnett, B, Graham, A, Olmsted, RA, and Chulay, JD. "Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus." Vaccine 25, no. 42 (2007): 7441-7449.  Full Text
• Teaching & Mentoring
• 

  Recent Courses

  • CRP 254: RESEARCH MANAGEMENT 2018

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.